P539: A PHASE 1 STUDY OF HMPL-306, A DUAL INHIBITOR OF MUTANT ISOCITRATE DEHYDROGENASE (IDH) 1 AND 2, IN PTS WITH RELAPSED/REFRACTORY MYELOID HEMATOLOGICAL MALIGNANCIES HARBORING IDH1 AND/OR 2 MUTATIONS

相似书籍

• Exploiting electrode nanoconfinement to investigate the catalytic properties of isocitrate dehydrogenase (IDH1) and a cancer-associated variant
  由: Herold, RA, et al.
  出版: (2021)
• Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma.
  由: Krell, D, et al.
  出版: (2011)
• GENETIC BIOMARKERS OF GLIAL BRAIN TUMORS: IDH1 AND IDH2 MUTATIONS
  由: M. Yu. Prokudin, et al.
  出版: (2020-09-01)
• Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations
  由: Emir, U, et al.
  出版: (2015)
• IDH1 and IDH2 mutations in myeloid neoplasms – Novel paradigms and clinical implications
  由: Mario Cazzola
  出版: (2010-10-01)